Use of surrogate endpoints vs. clinical outcome trials for registration trials

被引：0
|
作者：
Calvo, G. [1 ]
Suarez, M. L. [2 ]
Ruiz, M. [2 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] AEMPS, Madrid, Spain
来源：
PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2007年
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：5 / +
页数：2
相关论文
共 50 条
  • [21] Endpoints in oncologic registration trials
    Templeton, A.
    Thuerlimann, B.
    Shmitz, Hsu S-F
    ONKOLOGIE, 2011, 34 : 226 - 227
  • [22] Use of Imaging Endpoints in Clinical Trials
    Gillam, Linda D.
    Leipsic, Jonathon
    Weissman, Neil J.
    JACC-CARDIOVASCULAR IMAGING, 2017, 10 (03) : 296 - 303
  • [23] Use of composite endpoints in clinical trials
    Sankoh, Abdul J.
    Li, Haihong
    D'Agostino, Ralph B., Sr.
    STATISTICS IN MEDICINE, 2014, 33 (27) : 4709 - 4714
  • [24] Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
    Moncrieff, Marc D.
    Lo, Serigne
    Saw, Robyn
    Shannon, Kerwin
    Spillane, Andrew
    Stretch, Jonathan
    Heaton, Martin
    Snelling, Andrew
    Ch'ng, Sydney
    Nieweg, Omgo
    Thompson, John
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S32 - S32
  • [25] Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
    Jeeyapant, Atthanee
    Kingston, Hugh W.
    Plewes, Katherine
    Maude, Richard J.
    Hanson, Josh
    Herdman, M. Trent
    Leopold, Stije J.
    Ngernseng, Thatsanun
    Charunwatthanal', Prakaykaew
    Nguyen Hoan Phu
    Ghose, Aniruddha
    Hasan, M. Mahtab Uddin
    Fanello, Caterina I.
    Faiz, Md Abul
    Tran Tinh Hien
    Day, Nicholas P. J.
    White, Nicholas J.
    Dondorp, Arjen M.
    PLOS ONE, 2017, 12 (01):
  • [26] Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials
    Patel, Ravi B.
    Vaduganathan, Muthiah
    Samman-Tahhan, Ayman
    Kalogeropoulos, Andreas P.
    Georgiopoulou, Vasiliki V.
    Fonarow, Gregg C.
    Gheorghiade, Mihai
    Butler, Javed
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (11): : 1845 - 1850
  • [27] Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis
    Tsochatzis, Emmanuel A.
    Buzzetti, Elena
    Pinzani, Massimo
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (08): : 549 - 550
  • [28] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA
    PRENTICE, RL
    STATISTICS IN MEDICINE, 1989, 8 (04) : 431 - 440
  • [29] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - CARDIOVASCULAR-DISEASES
    WITTES, J
    LAKATOS, E
    PROBSTFIELD, J
    STATISTICS IN MEDICINE, 1989, 8 (04) : 415 - 425
  • [30] Biomarkers as surrogate endpoints in Alzheimer's disease clinical trials
    Kritsidima, M.
    Elferink, A. J.
    Wied, C. C. Gispen-de
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 33 - 33
12345